12:00 AM
 | 
Mar 15, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Results

PPRT-321: Phase II

PPRT said that in a 50-patient U.S. Phase II trial, PPRT-321 was safe across three doses...

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >